Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Insulin API industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Gulf Pharmaceutical Industries
Tonghua Dongbao
Eli Lilly-Aventis
Biocon
Gan & Lee Pharmaceuticals
United Laboratory
Yichang HEC Changjiang Pharmaceutical
Amphastar
Bioton
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Regular Human Insulin
Insulin Analogue
Application:
Short Acting
Intermediate Acting
Long Acting
Pre-mix Insulin
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Insulin API Industry Overview
-
1.1.1 Insulin API Market Scope and Market Segments
-
1.1.2 Insulin API Industry Characteristics
-
1.1.3 Global and China Insulin API Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Insulin API Production Value and Growth Rate (2017-2028)
-
1.2 Global Insulin API Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Regular Human Insulin
-
1.2.2 Insulin Analogue
-
1.3 Global Insulin API Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Short Acting
-
1.3.2 Intermediate Acting
-
1.3.3 Long Acting
-
1.3.4 Pre-mix Insulin
-
1.4 Market Analysis by Region
-
1.4.1 North America Insulin API Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Insulin API Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Insulin API Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Insulin API Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Insulin API Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Insulin API Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Insulin API Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Insulin API Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Insulin API Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Insulin API Industry Porter's Five Forces Model Analysis
-
2.2.3 Insulin API Industry PEST Analysis
-
2.3 Insulin API Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Insulin API Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Insulin API Industry
Chapter 3 Global and China Insulin API Market, by Manufacturer
-
3.1 Global and China Insulin API Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Insulin API Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Insulin API Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Insulin API Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Insulin API Market Top 3 Players
Chapter 4 Global and China Insulin API Market, by Type (2017-2028)
-
4.1 Insulin API Market Trend, by Type
-
4.2 Global Insulin API Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Insulin API Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Insulin API Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Insulin API Price Trend, by Type (2017-2028)
-
4.3 China Insulin API Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Insulin API Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Insulin API Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Insulin API Price Trend, by Type (2017-2028)
Chapter 5 Global and China Insulin API Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Insulin API Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Insulin API Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Insulin API Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Insulin API Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Insulin API Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Insulin API Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Insulin API Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Insulin API Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Insulin API Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Insulin API Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Insulin API Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Insulin API Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Insulin API Market Analysis
-
7.1 North America Insulin API Market, by Type
-
7.2 North America Insulin API Market, by Application
-
7.3 North America Insulin API Market Analysis and Forecast, by Country
-
7.3.1 United States Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Insulin API Market Analysis
-
8.1 Europe Insulin API Market, by Type
-
8.2 Europe Insulin API Market, by Application
-
8.3 Europe Insulin API Market Analysis and Forecast, by Country
-
8.3.1 Germany Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Insulin API Market Analysis
-
9.1 APAC Insulin API Market, by Type
-
9.2 APAC Insulin API Market, by Application
-
9.3 APAC Insulin API Market Analysis and Forecast, by Country
-
9.3.1 China Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Insulin API Market Analysis
-
10.1 Latin America, Middle East and Africa Insulin API Market, by Type
-
10.2 Latin America, Middle East and Africa Insulin API Market, by Application
-
10.3 Latin America, Middle East and Africa Insulin API Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Insulin API Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Insulin API Company Profiles
-
11.1 Gulf Pharmaceutical Industries
-
11.1.1 Gulf Pharmaceutical Industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Gulf Pharmaceutical Industries Insulin API Product Profiles, Application and Specification
-
11.1.3 Gulf Pharmaceutical Industries Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Tonghua Dongbao
-
11.2.1 Tonghua Dongbao Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Tonghua Dongbao Insulin API Product Profiles, Application and Specification
-
11.2.3 Tonghua Dongbao Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Eli Lilly-Aventis
-
11.3.1 Eli Lilly-Aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Eli Lilly-Aventis Insulin API Product Profiles, Application and Specification
-
11.3.3 Eli Lilly-Aventis Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Biocon
-
11.4.1 Biocon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Biocon Insulin API Product Profiles, Application and Specification
-
11.4.3 Biocon Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Gan & Lee Pharmaceuticals
-
11.5.1 Gan & Lee Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Gan & Lee Pharmaceuticals Insulin API Product Profiles, Application and Specification
-
11.5.3 Gan & Lee Pharmaceuticals Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 United Laboratory
-
11.6.1 United Laboratory Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 United Laboratory Insulin API Product Profiles, Application and Specification
-
11.6.3 United Laboratory Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Yichang HEC Changjiang Pharmaceutical
-
11.7.1 Yichang HEC Changjiang Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Yichang HEC Changjiang Pharmaceutical Insulin API Product Profiles, Application and Specification
-
11.7.3 Yichang HEC Changjiang Pharmaceutical Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Amphastar
-
11.8.1 Amphastar Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Amphastar Insulin API Product Profiles, Application and Specification
-
11.8.3 Amphastar Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Bioton
-
11.9.1 Bioton Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Bioton Insulin API Product Profiles, Application and Specification
-
11.9.3 Bioton Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Insulin API Industry Investment Prospect and Risk Assessment
-
12.1 Insulin API Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Insulin API Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure China Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Global Insulin API Production Value and Growth Rate (2017-2028)
-
Figure China Insulin API Production Value and Growth Rate (2017-2028)
-
Figure Global Insulin API Market Size and Growth Rate of Regular Human Insulin (2017-2028)
-
Figure Global Insulin API Market Size and Growth Rate of Insulin Analogue (2017-2028)
-
Figure Global Insulin API Market Size and Growth Rate of Short Acting (2017-2028)
-
Figure Global Insulin API Market Size and Growth Rate of Intermediate Acting (2017-2028)
-
Figure Global Insulin API Market Size and Growth Rate of Long Acting (2017-2028)
-
Figure Global Insulin API Market Size and Growth Rate of Pre-mix Insulin (2017-2028)
-
Figure North America Insulin API Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Insulin API Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Insulin API Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Insulin API Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Insulin API Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Insulin API Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Insulin API Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Insulin API Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Insulin API Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Insulin API Market Share, by Manufacturer in 2021
-
Figure Global and China Insulin API Market Share, by Manufacturer in 2022
-
Table Global Insulin API Sales Volume, by Type (2017-2028)
-
Table Global Insulin API Sales Volume Share, by Type (2017-2028)
-
Figure Global Insulin API Sales Volume Share, by Type (2017-2028)
-
Table Global Insulin API Sales Value, by Type (2017-2028)
-
Table Global Insulin API Sales Value Share, by Type (2017-2028)
-
Figure Global Insulin API Price Trend, by Type (2017-2028)
-
Table China Insulin API Sales Volume, by Type (2017-2028)
-
Table China Insulin API Sales Volume Share, by Type (2017-2028)
-
Figure China Insulin API Sales Volume Share, by Type (2017-2028)
-
Table China Insulin API Sales Value, by Type (2017-2028)
-
Table China Insulin API Sales Value Share, by Type (2017-2028)
-
Figure China Insulin API Price Trend, by Type (2017-2028)
-
Table Global Insulin API Sales Volume, by Application (2017-2028)
-
Table Global Insulin API Sales Volume Share, by Application (2017-2028)
-
Figure Global Insulin API Sales Volume Share, by Application (2017-2028)
-
Table Global Insulin API Sales Value, by Application (2017-2028)
-
Table Global Insulin API Sales Value Share, by Application (2017-2028)
-
Figure Global Insulin API Sales Value Share, by Application (2017-2028)
-
Table China Insulin API Sales Volume, by Application (2017-2028)
-
Table China Insulin API Sales Volume Share, by Application (2017-2028)
-
Figure China Insulin API Sales Volume Share, by Application (2017-2028)
-
Table China Insulin API Sales Value, by Application (2017-2028)
-
Table China Insulin API Sales Value Share, by Application (2017-2028)
-
Figure China Insulin API Sales Value Share, by Application (2017-2028)
-
Figure China Insulin API Production, Import, Consumption and Export (2017-2022)
-
Figure North America Insulin API Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Insulin API Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Insulin API Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Insulin API Production, Import, Consumption and Export (2017-2022)
-
Table North America Insulin API Sales Volume, by Type (2017-2028)
-
Table North America Insulin API Sales Volume Share, by Type (2017-2028)
-
Figure North America Insulin API Sales Volume Share, by Type (2017-2028)
-
Table North America Insulin API Sales Volume, by Application (2017-2028)
-
Table North America Insulin API Sales Volume Share, by Application (2017-2028)
-
Figure North America Insulin API Sales Volume Share, by Application (2017-2028)
-
Figure United States Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure United States Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure Canada Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Insulin API Sales Value and Growth Rate (2017-2028)
-
Table Europe Insulin API Sales Volume, by Type (2017-2028)
-
Table Europe Insulin API Sales Volume Share, by Type (2017-2028)
-
Figure Europe Insulin API Sales Volume Share, by Type (2017-2028)
-
Table Europe Insulin API Sales Volume, by Application (2017-2028)
-
Table Europe Insulin API Sales Volume Share, by Application (2017-2028)
-
Figure Europe Insulin API Sales Volume Share, by Application (2017-2028)
-
Figure Germany Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure UK Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure UK Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure France Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure France Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure Italy Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure Spain Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure Poland Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure Russia Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Insulin API Sales Value and Growth Rate (2017-2028)
-
Table APAC Insulin API Sales Volume, by Type (2017-2028)
-
Table APAC Insulin API Sales Volume Share, by Type (2017-2028)
-
Figure APAC Insulin API Sales Volume Share, by Type (2017-2028)
-
Table APAC Insulin API Sales Volume, by Application (2017-2028)
-
Table APAC Insulin API Sales Volume Share, by Application (2017-2028)
-
Figure APAC Insulin API Sales Volume Share, by Application (2017-2028)
-
Figure China Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure China Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure Japan Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure India Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure India Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Insulin API Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Insulin API Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Insulin API Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Insulin API Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Insulin API Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Insulin API Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Insulin API Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Insulin API Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Insulin API Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Insulin API Sales Value and Growth Rate (2017-2028)
-
Table Gulf Pharmaceutical Industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Gulf Pharmaceutical Industries Product Profiles, Application and Specification
-
Table Gulf Pharmaceutical Industries Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Tonghua Dongbao Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Tonghua Dongbao Product Profiles, Application and Specification
-
Table Tonghua Dongbao Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lilly-Aventis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly-Aventis Product Profiles, Application and Specification
-
Table Eli Lilly-Aventis Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biocon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biocon Product Profiles, Application and Specification
-
Table Biocon Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Gan & Lee Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Gan & Lee Pharmaceuticals Product Profiles, Application and Specification
-
Table Gan & Lee Pharmaceuticals Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table United Laboratory Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table United Laboratory Product Profiles, Application and Specification
-
Table United Laboratory Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Yichang HEC Changjiang Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Yichang HEC Changjiang Pharmaceutical Product Profiles, Application and Specification
-
Table Yichang HEC Changjiang Pharmaceutical Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amphastar Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amphastar Product Profiles, Application and Specification
-
Table Amphastar Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bioton Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bioton Product Profiles, Application and Specification
-
Table Bioton Insulin API Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
